Weight Loss – Marrero
Age 22 to 65
Sex Male or Female
Conditons Weight Loss
Weight Loss Research Study
Obese patients often also have Nonalcoholic Fatty Liver Disease (NAFLD). NAFLD prevalence in the general population has been estimated at 20%. Treatment of NAFLD/NASH generally includes weight loss and glycemic control if the patient is diabetic or prediabetic.
That is why Tandem Clinical Research is looking for volunteers for a research study of an investigational NAFLD medication designed to help reduce weight and liver fat. To qualify, you must:
- Be 22 to 65 years of age
- Be obese or overweight with or without diabetes
Qualified participants will receive study-related medication and care. Compensation for time and travel may be available. To learn more or schedule an appointment, complete the form below!